Global Onco-hematology Molecular Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Onco-hematology Molecular Testing market size was valued at USD 525.8 million in 2022 and is forecast to a readjusted size of USD 1159.6 million by 2029 with a CAGR of 12.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Onco-hematology Molecular Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Onco-hematology Molecular Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Onco-hematology Molecular Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Onco-hematology Molecular Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Onco-hematology Molecular Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Onco-hematology Molecular Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Onco-hematology Molecular Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Asusragen, Inc., Bio-Rad Laboratories,Inc., ICON Plc, Integrated DNA Technologies, Inc. and Illumina, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Onco-hematology Molecular Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Onco-hematology Molecular Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Onco-hematology Molecular Testing, with revenue, gross margin and global market share of Onco-hematology Molecular Testing from 2018 to 2023.
Chapter 3, the Onco-hematology Molecular Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Onco-hematology Molecular Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Onco-hematology Molecular Testing.
Chapter 13, to describe Onco-hematology Molecular Testing research findings and conclusion.
This report is a detailed and comprehensive analysis for global Onco-hematology Molecular Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Onco-hematology Molecular Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Onco-hematology Molecular Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Onco-hematology Molecular Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Onco-hematology Molecular Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Onco-hematology Molecular Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Onco-hematology Molecular Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Asusragen, Inc., Bio-Rad Laboratories,Inc., ICON Plc, Integrated DNA Technologies, Inc. and Illumina, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Onco-hematology Molecular Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- qPCR
- dPCR
- Next-Generation Sequencing
- Others
- National Reference Lab / Specialty Lab
- University Hospital
- Community Hospital
- Asusragen, Inc.
- Bio-Rad Laboratories,Inc.
- ICON Plc
- Integrated DNA Technologies, Inc.
- Illumina, Inc.
- Invivoscribe, Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific, Inc.
- Cepheid
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Onco-hematology Molecular Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Onco-hematology Molecular Testing, with revenue, gross margin and global market share of Onco-hematology Molecular Testing from 2018 to 2023.
Chapter 3, the Onco-hematology Molecular Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Onco-hematology Molecular Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Onco-hematology Molecular Testing.
Chapter 13, to describe Onco-hematology Molecular Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Onco-hematology Molecular Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Onco-hematology Molecular Testing by Type
1.3.1 Overview: Global Onco-hematology Molecular Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Onco-hematology Molecular Testing Consumption Value Market Share by Type in 2022
1.3.3 qPCR
1.3.4 dPCR
1.3.5 Next-Generation Sequencing
1.3.6 Others
1.4 Global Onco-hematology Molecular Testing Market by Application
1.4.1 Overview: Global Onco-hematology Molecular Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 National Reference Lab / Specialty Lab
1.4.3 University Hospital
1.4.4 Community Hospital
1.5 Global Onco-hematology Molecular Testing Market Size & Forecast
1.6 Global Onco-hematology Molecular Testing Market Size and Forecast by Region
1.6.1 Global Onco-hematology Molecular Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Onco-hematology Molecular Testing Market Size by Region, (2018-2029)
1.6.3 North America Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
1.6.6 South America Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Asusragen, Inc.
2.1.1 Asusragen, Inc. Details
2.1.2 Asusragen, Inc. Major Business
2.1.3 Asusragen, Inc. Onco-hematology Molecular Testing Product and Solutions
2.1.4 Asusragen, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Asusragen, Inc. Recent Developments and Future Plans
2.2 Bio-Rad Laboratories,Inc.
2.2.1 Bio-Rad Laboratories,Inc. Details
2.2.2 Bio-Rad Laboratories,Inc. Major Business
2.2.3 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product and Solutions
2.2.4 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Rad Laboratories,Inc. Recent Developments and Future Plans
2.3 ICON Plc
2.3.1 ICON Plc Details
2.3.2 ICON Plc Major Business
2.3.3 ICON Plc Onco-hematology Molecular Testing Product and Solutions
2.3.4 ICON Plc Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ICON Plc Recent Developments and Future Plans
2.4 Integrated DNA Technologies, Inc.
2.4.1 Integrated DNA Technologies, Inc. Details
2.4.2 Integrated DNA Technologies, Inc. Major Business
2.4.3 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product and Solutions
2.4.4 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Integrated DNA Technologies, Inc. Recent Developments and Future Plans
2.5 Illumina, Inc.
2.5.1 Illumina, Inc. Details
2.5.2 Illumina, Inc. Major Business
2.5.3 Illumina, Inc. Onco-hematology Molecular Testing Product and Solutions
2.5.4 Illumina, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Illumina, Inc. Recent Developments and Future Plans
2.6 Invivoscribe, Inc.
2.6.1 Invivoscribe, Inc. Details
2.6.2 Invivoscribe, Inc. Major Business
2.6.3 Invivoscribe, Inc. Onco-hematology Molecular Testing Product and Solutions
2.6.4 Invivoscribe, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Invivoscribe, Inc. Recent Developments and Future Plans
2.7 QIAGEN N.V.
2.7.1 QIAGEN N.V. Details
2.7.2 QIAGEN N.V. Major Business
2.7.3 QIAGEN N.V. Onco-hematology Molecular Testing Product and Solutions
2.7.4 QIAGEN N.V. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 QIAGEN N.V. Recent Developments and Future Plans
2.8 Thermo Fisher Scientific, Inc.
2.8.1 Thermo Fisher Scientific, Inc. Details
2.8.2 Thermo Fisher Scientific, Inc. Major Business
2.8.3 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product and Solutions
2.8.4 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.9 Cepheid
2.9.1 Cepheid Details
2.9.2 Cepheid Major Business
2.9.3 Cepheid Onco-hematology Molecular Testing Product and Solutions
2.9.4 Cepheid Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cepheid Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Onco-hematology Molecular Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Onco-hematology Molecular Testing by Company Revenue
3.2.2 Top 3 Onco-hematology Molecular Testing Players Market Share in 2022
3.2.3 Top 6 Onco-hematology Molecular Testing Players Market Share in 2022
3.3 Onco-hematology Molecular Testing Market: Overall Company Footprint Analysis
3.3.1 Onco-hematology Molecular Testing Market: Region Footprint
3.3.2 Onco-hematology Molecular Testing Market: Company Product Type Footprint
3.3.3 Onco-hematology Molecular Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Onco-hematology Molecular Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Onco-hematology Molecular Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Onco-hematology Molecular Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
6.2 North America Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
6.3 North America Onco-hematology Molecular Testing Market Size by Country
6.3.1 North America Onco-hematology Molecular Testing Consumption Value by Country (2018-2029)
6.3.2 United States Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
7.2 Europe Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
7.3 Europe Onco-hematology Molecular Testing Market Size by Country
7.3.1 Europe Onco-hematology Molecular Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7.3.3 France Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Onco-hematology Molecular Testing Market Size by Region
8.3.1 Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Region (2018-2029)
8.3.2 China Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.5 India Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
9.2 South America Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
9.3 South America Onco-hematology Molecular Testing Market Size by Country
9.3.1 South America Onco-hematology Molecular Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Onco-hematology Molecular Testing Market Size by Country
10.3.1 Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Onco-hematology Molecular Testing Market Drivers
11.2 Onco-hematology Molecular Testing Market Restraints
11.3 Onco-hematology Molecular Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Onco-hematology Molecular Testing Industry Chain
12.2 Onco-hematology Molecular Testing Upstream Analysis
12.3 Onco-hematology Molecular Testing Midstream Analysis
12.4 Onco-hematology Molecular Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Onco-hematology Molecular Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Onco-hematology Molecular Testing by Type
1.3.1 Overview: Global Onco-hematology Molecular Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Onco-hematology Molecular Testing Consumption Value Market Share by Type in 2022
1.3.3 qPCR
1.3.4 dPCR
1.3.5 Next-Generation Sequencing
1.3.6 Others
1.4 Global Onco-hematology Molecular Testing Market by Application
1.4.1 Overview: Global Onco-hematology Molecular Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 National Reference Lab / Specialty Lab
1.4.3 University Hospital
1.4.4 Community Hospital
1.5 Global Onco-hematology Molecular Testing Market Size & Forecast
1.6 Global Onco-hematology Molecular Testing Market Size and Forecast by Region
1.6.1 Global Onco-hematology Molecular Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Onco-hematology Molecular Testing Market Size by Region, (2018-2029)
1.6.3 North America Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
1.6.6 South America Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Onco-hematology Molecular Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Asusragen, Inc.
2.1.1 Asusragen, Inc. Details
2.1.2 Asusragen, Inc. Major Business
2.1.3 Asusragen, Inc. Onco-hematology Molecular Testing Product and Solutions
2.1.4 Asusragen, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Asusragen, Inc. Recent Developments and Future Plans
2.2 Bio-Rad Laboratories,Inc.
2.2.1 Bio-Rad Laboratories,Inc. Details
2.2.2 Bio-Rad Laboratories,Inc. Major Business
2.2.3 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product and Solutions
2.2.4 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Rad Laboratories,Inc. Recent Developments and Future Plans
2.3 ICON Plc
2.3.1 ICON Plc Details
2.3.2 ICON Plc Major Business
2.3.3 ICON Plc Onco-hematology Molecular Testing Product and Solutions
2.3.4 ICON Plc Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ICON Plc Recent Developments and Future Plans
2.4 Integrated DNA Technologies, Inc.
2.4.1 Integrated DNA Technologies, Inc. Details
2.4.2 Integrated DNA Technologies, Inc. Major Business
2.4.3 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product and Solutions
2.4.4 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Integrated DNA Technologies, Inc. Recent Developments and Future Plans
2.5 Illumina, Inc.
2.5.1 Illumina, Inc. Details
2.5.2 Illumina, Inc. Major Business
2.5.3 Illumina, Inc. Onco-hematology Molecular Testing Product and Solutions
2.5.4 Illumina, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Illumina, Inc. Recent Developments and Future Plans
2.6 Invivoscribe, Inc.
2.6.1 Invivoscribe, Inc. Details
2.6.2 Invivoscribe, Inc. Major Business
2.6.3 Invivoscribe, Inc. Onco-hematology Molecular Testing Product and Solutions
2.6.4 Invivoscribe, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Invivoscribe, Inc. Recent Developments and Future Plans
2.7 QIAGEN N.V.
2.7.1 QIAGEN N.V. Details
2.7.2 QIAGEN N.V. Major Business
2.7.3 QIAGEN N.V. Onco-hematology Molecular Testing Product and Solutions
2.7.4 QIAGEN N.V. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 QIAGEN N.V. Recent Developments and Future Plans
2.8 Thermo Fisher Scientific, Inc.
2.8.1 Thermo Fisher Scientific, Inc. Details
2.8.2 Thermo Fisher Scientific, Inc. Major Business
2.8.3 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product and Solutions
2.8.4 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.9 Cepheid
2.9.1 Cepheid Details
2.9.2 Cepheid Major Business
2.9.3 Cepheid Onco-hematology Molecular Testing Product and Solutions
2.9.4 Cepheid Onco-hematology Molecular Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cepheid Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Onco-hematology Molecular Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Onco-hematology Molecular Testing by Company Revenue
3.2.2 Top 3 Onco-hematology Molecular Testing Players Market Share in 2022
3.2.3 Top 6 Onco-hematology Molecular Testing Players Market Share in 2022
3.3 Onco-hematology Molecular Testing Market: Overall Company Footprint Analysis
3.3.1 Onco-hematology Molecular Testing Market: Region Footprint
3.3.2 Onco-hematology Molecular Testing Market: Company Product Type Footprint
3.3.3 Onco-hematology Molecular Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Onco-hematology Molecular Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Onco-hematology Molecular Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Onco-hematology Molecular Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
6.2 North America Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
6.3 North America Onco-hematology Molecular Testing Market Size by Country
6.3.1 North America Onco-hematology Molecular Testing Consumption Value by Country (2018-2029)
6.3.2 United States Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
7.2 Europe Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
7.3 Europe Onco-hematology Molecular Testing Market Size by Country
7.3.1 Europe Onco-hematology Molecular Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7.3.3 France Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Onco-hematology Molecular Testing Market Size by Region
8.3.1 Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Region (2018-2029)
8.3.2 China Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.5 India Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
9.2 South America Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
9.3 South America Onco-hematology Molecular Testing Market Size by Country
9.3.1 South America Onco-hematology Molecular Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Onco-hematology Molecular Testing Market Size by Country
10.3.1 Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Onco-hematology Molecular Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Onco-hematology Molecular Testing Market Drivers
11.2 Onco-hematology Molecular Testing Market Restraints
11.3 Onco-hematology Molecular Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Onco-hematology Molecular Testing Industry Chain
12.2 Onco-hematology Molecular Testing Upstream Analysis
12.3 Onco-hematology Molecular Testing Midstream Analysis
12.4 Onco-hematology Molecular Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Onco-hematology Molecular Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Onco-hematology Molecular Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Onco-hematology Molecular Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Onco-hematology Molecular Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Asusragen, Inc. Company Information, Head Office, and Major Competitors
Table 6. Asusragen, Inc. Major Business
Table 7. Asusragen, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 8. Asusragen, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Asusragen, Inc. Recent Developments and Future Plans
Table 10. Bio-Rad Laboratories,Inc. Company Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories,Inc. Major Business
Table 12. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product and Solutions
Table 13. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bio-Rad Laboratories,Inc. Recent Developments and Future Plans
Table 15. ICON Plc Company Information, Head Office, and Major Competitors
Table 16. ICON Plc Major Business
Table 17. ICON Plc Onco-hematology Molecular Testing Product and Solutions
Table 18. ICON Plc Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. ICON Plc Recent Developments and Future Plans
Table 20. Integrated DNA Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 21. Integrated DNA Technologies, Inc. Major Business
Table 22. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 23. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Integrated DNA Technologies, Inc. Recent Developments and Future Plans
Table 25. Illumina, Inc. Company Information, Head Office, and Major Competitors
Table 26. Illumina, Inc. Major Business
Table 27. Illumina, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 28. Illumina, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Illumina, Inc. Recent Developments and Future Plans
Table 30. Invivoscribe, Inc. Company Information, Head Office, and Major Competitors
Table 31. Invivoscribe, Inc. Major Business
Table 32. Invivoscribe, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 33. Invivoscribe, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Invivoscribe, Inc. Recent Developments and Future Plans
Table 35. QIAGEN N.V. Company Information, Head Office, and Major Competitors
Table 36. QIAGEN N.V. Major Business
Table 37. QIAGEN N.V. Onco-hematology Molecular Testing Product and Solutions
Table 38. QIAGEN N.V. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. QIAGEN N.V. Recent Developments and Future Plans
Table 40. Thermo Fisher Scientific, Inc. Company Information, Head Office, and Major Competitors
Table 41. Thermo Fisher Scientific, Inc. Major Business
Table 42. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 43. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Table 45. Cepheid Company Information, Head Office, and Major Competitors
Table 46. Cepheid Major Business
Table 47. Cepheid Onco-hematology Molecular Testing Product and Solutions
Table 48. Cepheid Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Cepheid Recent Developments and Future Plans
Table 50. Global Onco-hematology Molecular Testing Revenue (USD Million) by Players (2018-2023)
Table 51. Global Onco-hematology Molecular Testing Revenue Share by Players (2018-2023)
Table 52. Breakdown of Onco-hematology Molecular Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Onco-hematology Molecular Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key Onco-hematology Molecular Testing Players
Table 55. Onco-hematology Molecular Testing Market: Company Product Type Footprint
Table 56. Onco-hematology Molecular Testing Market: Company Product Application Footprint
Table 57. Onco-hematology Molecular Testing New Market Entrants and Barriers to Market Entry
Table 58. Onco-hematology Molecular Testing Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Onco-hematology Molecular Testing Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global Onco-hematology Molecular Testing Consumption Value Share by Type (2018-2023)
Table 61. Global Onco-hematology Molecular Testing Consumption Value Forecast by Type (2024-2029)
Table 62. Global Onco-hematology Molecular Testing Consumption Value by Application (2018-2023)
Table 63. Global Onco-hematology Molecular Testing Consumption Value Forecast by Application (2024-2029)
Table 64. North America Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America Onco-hematology Molecular Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America Onco-hematology Molecular Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe Onco-hematology Molecular Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Onco-hematology Molecular Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America Onco-hematology Molecular Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America Onco-hematology Molecular Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 94. Onco-hematology Molecular Testing Raw Material
Table 95. Key Suppliers of Onco-hematology Molecular Testing Raw Materials
Table 1. Global Onco-hematology Molecular Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Onco-hematology Molecular Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Onco-hematology Molecular Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Onco-hematology Molecular Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Asusragen, Inc. Company Information, Head Office, and Major Competitors
Table 6. Asusragen, Inc. Major Business
Table 7. Asusragen, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 8. Asusragen, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Asusragen, Inc. Recent Developments and Future Plans
Table 10. Bio-Rad Laboratories,Inc. Company Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories,Inc. Major Business
Table 12. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Product and Solutions
Table 13. Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Bio-Rad Laboratories,Inc. Recent Developments and Future Plans
Table 15. ICON Plc Company Information, Head Office, and Major Competitors
Table 16. ICON Plc Major Business
Table 17. ICON Plc Onco-hematology Molecular Testing Product and Solutions
Table 18. ICON Plc Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. ICON Plc Recent Developments and Future Plans
Table 20. Integrated DNA Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 21. Integrated DNA Technologies, Inc. Major Business
Table 22. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 23. Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Integrated DNA Technologies, Inc. Recent Developments and Future Plans
Table 25. Illumina, Inc. Company Information, Head Office, and Major Competitors
Table 26. Illumina, Inc. Major Business
Table 27. Illumina, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 28. Illumina, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Illumina, Inc. Recent Developments and Future Plans
Table 30. Invivoscribe, Inc. Company Information, Head Office, and Major Competitors
Table 31. Invivoscribe, Inc. Major Business
Table 32. Invivoscribe, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 33. Invivoscribe, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Invivoscribe, Inc. Recent Developments and Future Plans
Table 35. QIAGEN N.V. Company Information, Head Office, and Major Competitors
Table 36. QIAGEN N.V. Major Business
Table 37. QIAGEN N.V. Onco-hematology Molecular Testing Product and Solutions
Table 38. QIAGEN N.V. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. QIAGEN N.V. Recent Developments and Future Plans
Table 40. Thermo Fisher Scientific, Inc. Company Information, Head Office, and Major Competitors
Table 41. Thermo Fisher Scientific, Inc. Major Business
Table 42. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Product and Solutions
Table 43. Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Table 45. Cepheid Company Information, Head Office, and Major Competitors
Table 46. Cepheid Major Business
Table 47. Cepheid Onco-hematology Molecular Testing Product and Solutions
Table 48. Cepheid Onco-hematology Molecular Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Cepheid Recent Developments and Future Plans
Table 50. Global Onco-hematology Molecular Testing Revenue (USD Million) by Players (2018-2023)
Table 51. Global Onco-hematology Molecular Testing Revenue Share by Players (2018-2023)
Table 52. Breakdown of Onco-hematology Molecular Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Onco-hematology Molecular Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 54. Head Office of Key Onco-hematology Molecular Testing Players
Table 55. Onco-hematology Molecular Testing Market: Company Product Type Footprint
Table 56. Onco-hematology Molecular Testing Market: Company Product Application Footprint
Table 57. Onco-hematology Molecular Testing New Market Entrants and Barriers to Market Entry
Table 58. Onco-hematology Molecular Testing Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Onco-hematology Molecular Testing Consumption Value (USD Million) by Type (2018-2023)
Table 60. Global Onco-hematology Molecular Testing Consumption Value Share by Type (2018-2023)
Table 61. Global Onco-hematology Molecular Testing Consumption Value Forecast by Type (2024-2029)
Table 62. Global Onco-hematology Molecular Testing Consumption Value by Application (2018-2023)
Table 63. Global Onco-hematology Molecular Testing Consumption Value Forecast by Application (2024-2029)
Table 64. North America Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 65. North America Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 66. North America Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 67. North America Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 68. North America Onco-hematology Molecular Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 69. North America Onco-hematology Molecular Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 70. Europe Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Europe Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Europe Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 73. Europe Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 74. Europe Onco-hematology Molecular Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Onco-hematology Molecular Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 77. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 78. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 79. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 80. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 81. Asia-Pacific Onco-hematology Molecular Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 82. South America Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 83. South America Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 84. South America Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 85. South America Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 86. South America Onco-hematology Molecular Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 87. South America Onco-hematology Molecular Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 89. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 90. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 91. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 92. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 93. Middle East & Africa Onco-hematology Molecular Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 94. Onco-hematology Molecular Testing Raw Material
Table 95. Key Suppliers of Onco-hematology Molecular Testing Raw Materials
LIST OF FIGURES
Figure 1. Onco-hematology Molecular Testing Picture
Figure 2. Global Onco-hematology Molecular Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Onco-hematology Molecular Testing Consumption Value Market Share by Type in 2022
Figure 4. qPCR
Figure 5. dPCR
Figure 6. Next-Generation Sequencing
Figure 7. Others
Figure 8. Global Onco-hematology Molecular Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Onco-hematology Molecular Testing Consumption Value Market Share by Application in 2022
Figure 10. National Reference Lab / Specialty Lab Picture
Figure 11. University Hospital Picture
Figure 12. Community Hospital Picture
Figure 13. Global Onco-hematology Molecular Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Onco-hematology Molecular Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Onco-hematology Molecular Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Onco-hematology Molecular Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Onco-hematology Molecular Testing Consumption Value Market Share by Region in 2022
Figure 18. North America Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Onco-hematology Molecular Testing Revenue Share by Players in 2022
Figure 24. Onco-hematology Molecular Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Onco-hematology Molecular Testing Market Share in 2022
Figure 26. Global Top 6 Players Onco-hematology Molecular Testing Market Share in 2022
Figure 27. Global Onco-hematology Molecular Testing Consumption Value Share by Type (2018-2023)
Figure 28. Global Onco-hematology Molecular Testing Market Share Forecast by Type (2024-2029)
Figure 29. Global Onco-hematology Molecular Testing Consumption Value Share by Application (2018-2023)
Figure 30. Global Onco-hematology Molecular Testing Market Share Forecast by Application (2024-2029)
Figure 31. North America Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Onco-hematology Molecular Testing Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Onco-hematology Molecular Testing Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. France Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Onco-hematology Molecular Testing Consumption Value Market Share by Region (2018-2029)
Figure 48. China Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. India Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Onco-hematology Molecular Testing Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Onco-hematology Molecular Testing Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 65. Onco-hematology Molecular Testing Market Drivers
Figure 66. Onco-hematology Molecular Testing Market Restraints
Figure 67. Onco-hematology Molecular Testing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Onco-hematology Molecular Testing in 2022
Figure 70. Manufacturing Process Analysis of Onco-hematology Molecular Testing
Figure 71. Onco-hematology Molecular Testing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Onco-hematology Molecular Testing Picture
Figure 2. Global Onco-hematology Molecular Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Onco-hematology Molecular Testing Consumption Value Market Share by Type in 2022
Figure 4. qPCR
Figure 5. dPCR
Figure 6. Next-Generation Sequencing
Figure 7. Others
Figure 8. Global Onco-hematology Molecular Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Onco-hematology Molecular Testing Consumption Value Market Share by Application in 2022
Figure 10. National Reference Lab / Specialty Lab Picture
Figure 11. University Hospital Picture
Figure 12. Community Hospital Picture
Figure 13. Global Onco-hematology Molecular Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Onco-hematology Molecular Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Onco-hematology Molecular Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Onco-hematology Molecular Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Onco-hematology Molecular Testing Consumption Value Market Share by Region in 2022
Figure 18. North America Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Onco-hematology Molecular Testing Revenue Share by Players in 2022
Figure 24. Onco-hematology Molecular Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Onco-hematology Molecular Testing Market Share in 2022
Figure 26. Global Top 6 Players Onco-hematology Molecular Testing Market Share in 2022
Figure 27. Global Onco-hematology Molecular Testing Consumption Value Share by Type (2018-2023)
Figure 28. Global Onco-hematology Molecular Testing Market Share Forecast by Type (2024-2029)
Figure 29. Global Onco-hematology Molecular Testing Consumption Value Share by Application (2018-2023)
Figure 30. Global Onco-hematology Molecular Testing Market Share Forecast by Application (2024-2029)
Figure 31. North America Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Onco-hematology Molecular Testing Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Onco-hematology Molecular Testing Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. France Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Onco-hematology Molecular Testing Consumption Value Market Share by Region (2018-2029)
Figure 48. China Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. India Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Onco-hematology Molecular Testing Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Onco-hematology Molecular Testing Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Onco-hematology Molecular Testing Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Onco-hematology Molecular Testing Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Onco-hematology Molecular Testing Consumption Value (2018-2029) & (USD Million)
Figure 65. Onco-hematology Molecular Testing Market Drivers
Figure 66. Onco-hematology Molecular Testing Market Restraints
Figure 67. Onco-hematology Molecular Testing Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Onco-hematology Molecular Testing in 2022
Figure 70. Manufacturing Process Analysis of Onco-hematology Molecular Testing
Figure 71. Onco-hematology Molecular Testing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
